253 related articles for article (PubMed ID: 26359040)
1. [The inhibitory effect of metformin on oral squamous cell carcinoma].
Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Yasuda A; Kondo S; Nagumo T; Tsukamoto H; Mukudai Y; Umezawa K; Shintani S
Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
Yoshimura H; Yoshida H; Matsuda S; Ryoke T; Ohta K; Ohmori M; Yamamoto S; Kiyoshima T; Kobayashi M; Sano K
Mol Med Rep; 2019 Aug; 20(2):1139-1148. PubMed ID: 31173211
[TBL] [Abstract][Full Text] [Related]
5. Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma.
Ren A; Qiu Y; Cui H; Fu G
Oral Dis; 2015 Jul; 21(5):558-64. PubMed ID: 25581076
[TBL] [Abstract][Full Text] [Related]
6. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
7. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma.
Wang J; Jia L; Kuang Z; Wu T; Hong Y; Chen X; Leung WK; Xia J; Cheng B
PLoS One; 2014; 9(6):e98885. PubMed ID: 24892421
[TBL] [Abstract][Full Text] [Related]
9. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
11. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
Chen H; Sa G; Li L; He S; Wu T
Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
[TBL] [Abstract][Full Text] [Related]
13. Morphine inhibits cell viability and growth via suppression of vascular endothelial growth factor in human oral cancer HSC-3 cells.
Nishiwada T; Kawaraguchi Y; Uemura K; Kawaguchi M
J Anesth; 2019 Jun; 33(3):408-415. PubMed ID: 31049688
[TBL] [Abstract][Full Text] [Related]
14. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of the anticancer efficacy of quercetin in oral cancer cells.
Chen SF; Nien S; Wu CH; Liu CL; Chang YC; Lin YS
J Chin Med Assoc; 2013 Mar; 76(3):146-52. PubMed ID: 23497967
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
17. [Role of 8-allyl Garcinol in the Chemoprevention of Oral Squamous Cell Carcinoma].
Dong HT; Cao J; Han CM; Su Y; Zhang XY; Chen X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):1-10. PubMed ID: 30837036
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of CoCl2 induced hypoxic cell model of oral squamous cell carcinoma and a preliminary study on the biological behaviour change].
Han S; Han W; Ni Y; Wang Z; Hu Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Mar; 50(3):173-7. PubMed ID: 26081859
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor effects of chloroquine on oral squamous cell carcinoma.
Jia L; Wang J; Wu T; Wu J; Ling J; Cheng B
Mol Med Rep; 2017 Nov; 16(5):5779-5786. PubMed ID: 28849182
[TBL] [Abstract][Full Text] [Related]
20. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells.
Chen XR; Lu R; Dan HX; Liao G; Zhou M; Li XY; Ji N
Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
